---
$id: https://graph.org.ai/products/commodity/51142549
$type: Product
source: UNSPSC
code: "51142549"
title: "Carbidopa anhydrous"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Carbidopa anhydrous

**UNSPSC Code**: 51142549
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C10H14N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KR87B45RGH, chemically known as benzenepropanoic acid, .alpha.-hydrazino-3,4-dihydroxy-.alpha.-methyl-, (s)-, but more generally known as carbidopa anhydrous, which bears US NIH Compound Identifier 34359. European Medicines Agency schedules carbidopa anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06126MIG. Most nations, for tariff purposes, schedule carbidopa anhydrous under HS 29280090. Carbidopa anhydrous bears US NLM identifiers UMLS ID C1881339 and NCI Concept Code C61803. SMILES: C[C@](CC1CCC(C(C1)O)O)(C(=O)O)NN.

